PATENT CLAIM ANALYSIS

Application Number: 16184018
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "186100"]

Abstract:
The present invention belongs to the field of compliance markers and marker vaccines which allow for the differentiation between infected and vaccinated individuals. In particular, it relates to a method of determining whether an individual has received an immunogenic composition comprising a recombinant protein produced by a baculovirus expression system in cultured insect cells.

Claim (Index 50):
The method of  claim 48 , wherein the recombinant protein is a hemagglutinin of an avian influenza H5N1 virus and has at least 95% sequence identity with SEQ ID NO:24.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.16327
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15061690', '15562167', '13297125', '15801754', '15265545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6975963532011358
- 35 USC 102 Novelty (BERT): 0.5453030396312604
- Combined Prediction Score: 0.6823670218441483
- Mean Citation Score: 277.989544
- Max Citation Score: 377.1685
- Similarity Product: 295.4063371118903

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test